The Effect of Rosiglitazone on Ischemia-reperfusion-injury Using Annexin A5 Scintigraphy.

Clinical trial NCT00405015 · COMPLETED

Trial details

NCT number: NCT00405015
Sponsor: Radboud University Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ischemia-Reperfusion Injury The Metabolic Syndrome

Start date: 2007-04-01
Primary completion: 2008-07-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.